Picture of the Week and Clinical Case Presentations: 

  • To apply the principles of evidence-based medicine in the diagnosis and work-up of children with hematological and oncological diseases
  • To design and apply a treatment plan for patients with hematological and oncological diseases
  • To evaluate and manage the treatment and potential complications patients with complex hematological and oncological disorders experience 

EBM: Reviewing Evidence of how to Improve Hydroxyurea Adherence in the Pediatric Sickle Cell Population

  • Investigate the barriers to hydroxyurea adherence in children with sickle cell disease 
  • Exploring the most up to date strategies proven to increase adherence to hydroxyurea in children with sickle cell disease

 

Session date: 
12/18/2025 - 1:00pm to 3:00pm EST
Location: 
Children's National Hospital
111 Michigan Avenue NW
Washington, DC 20010
United States
  • 2.00 AMA PRA Category 1 Credit
    Children’s National Hospital designates this Live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 ANCC
    Children’s National Hospital will provide 2.00 Nursing Contact Hours for this Live activity.
  • 2.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Course Director(s)

Liny John, MD

has no relevant financial relationships to disclose at this time.

Birte Wistinghausen, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Charles D'Alessandro

has no relevant financial relationships to disclose at this time.

Birte Wistinghausen, MD

has no relevant financial relationships to disclose at this time.